Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 720-724

Spandidos Publications

Access to resources Recommend Favorite

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

By Kinch Amelie   Baecklund Eva   Backlin Carin   Ekman Tor   Molin Daniel   Tufveson Gunnar   Fernberg Pia   Sundström Christer   Pauksens Karlis   Enblad Gunilla  

Acta Oncologica, Vol. 53, Iss. 5, 2014-05 ,pp. : 669-679

Informa Healthcare

Access to resources Recommend Favorite

Large granular lymphocyte leukemia associated with hepatitis C virus infection and B cell lymphoma: improvement after antiviral therapy

By Poullot Elsa  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1797-1799

Informa Healthcare

Access to resources Recommend Favorite

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

By Wang Bufei   Huang Huiqiang   Bu Qing   Xia Zhongjun   Lin Xubin   Wang Fenghua   Li Yuhong   Peng Yulong   Pan Zhanhe   Wang Shusen   Lin Tongyu   Jiang Wenqi   Guan Zhongzhen  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite